The limited sensibility of DPYD genotyping significantly limits its clinical use.
Plasma and salivary DPD tests can detect patients at risk of severe toxicity.
Salivary [UH2]/[U] ratio performed better than plasma.
Salivary test had 85.7% sensitivity and 76.9% specificity to predict severe toxicity.